Loading...
•
Mar 31, 2020
Prothena Q1 2020 Earnings Report
Reported financial results and provided R&D update and updated financial guidance.
Key Takeaways
Prothena reported a net loss of $23.6 million for the first quarter of 2020, with total revenue of $0.1 million from its collaboration with Roche. The company's cash and restricted cash position was $355.4 million as of March 31, 2020.
Net loss was $23.6 million, compared to $20.9 million in Q1 2019.
Total revenue was $0.1 million, all from the collaboration with Roche, compared to $0.2 million in Q1 2019.
Research and development expenses totaled $15.2 million, compared to $13.3 million in Q1 2019.
Cash, cash equivalents, and restricted cash totaled $355.4 million as of March 31, 2020.
Prothena
Prothena
Prothena Revenue by Segment
Revenue by Segment
Collaboration Revenue
CapyFin.com Forward Guidance
Prothena is updating its projected full year 2020 net cash burn from operating and investing activities, and expects it to be $75 to $85 million and expects to end the year with approximately $299 million in cash, cash equivalents and restricted cash.